G9938 Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period
Billable / valid for submission HCPCS Release 2026Q3
Short description: Pt 66+ snp or ltc pos > 90d
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period | yes |
Related codes in G99
- G9900 Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified
- G9901 Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
- G9902 Patient screened for tobacco use and identified as a tobacco user
- G9903 Patient screened for tobacco use and identified as a tobacco non-user
- G9905 Patient not screened for tobacco use
- G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- G9908 Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- G9910 Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
- G9911 Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy
- G9912 Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
- G9913 Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified
- G9914 Patient initiated an anti-tnf agent
- G9915 No record of hbv results documented
- G9916 Functional status performed once in the last 12 months
- G9917 Documentation of advanced stage dementia and caregiver knowledge is limited
- G9918 Functional status not performed, reason not otherwise specified
- G9919 Screening performed and positive and provision of recommendations
- G9920 Screening performed and negative
- G9922 Safety concerns screen provided and if positive then documented mitigation recommendations
- G9923 Safety concerns screen provided and negative